Abstract
Chronic kidney disease (CKD) is an important determinant of the poor health outcome for major noncommunicable diseases that are the leading cause of death worldwide. Early recognition with screening programs of CKD and co-morbid conditions, like hypertension, diabetes, or toxic environments, can potentially slow progression to renal failure, improve quality of life and reduce healthcare cost. Effective multimodal tools are available to prevent CKD by managing its risk factors, and to slow or even halt disease progression to end-stage renal failure (ESRF). They can be adapted even to poor-resource settings of low- and middle-income countries for individual at high risk of CKD. CKD is also linked to acute kidney injury (AKI), that in poorest part of Africa, Asia and Latin America is preventable, treatable and often reversible, if managed adequately and in timely manner as proposed by the program "AKI 0by25" launched by the international Society of Nephrology in 2013. In addition to saving lives, prevention programs will create major heath gains, eventually reducing the current health inequity that arises from unaffordable or unobtainable renal replacement therapies in many part of the developing world if ESRF is not prevented.
Similar content being viewed by others
References
GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171
WHO (2002) The world health report 2002. World Health Organization, Geneva
WHO (2005) Preventing chronic disease: a vital investment. World Health Organization, Geneva
Murray C, Lopez A (1996) The global burden of disease. Harvard School of Public Health, Boston
International Diabetes Federation (2015) International Diabetes Federation, Diabetes Atlas, 7th edn. International Diabetes Federation, Brussels
King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431
Levitt NS (2008) Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94:1376–1382
International Diabetes Federation (2009) International Diabetes Federation, Diabetes Atlas, 4th edn. International Diabetes Federation, Brussels
Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800
Couser WG, Remuzzi G, Mendis S, Tonelli M (2011) The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80:1258–1270
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128
Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M (2015) Maintenance dialysis throughout the world in years 1990 and 2010. J Am Soc Nephrol 26:2621–2633
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:1975–1982
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382:260–272
Remuzzi G, Perico N (2014) International Society of Nephrology’s perspective on the emergence of chronic kidney diseases of unknown/undetermined etiology. MEDICC Rev 16:75–76
Vassalotti JA, Li S, McCullough PA, Bakris GL (2010) Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin Nephrol 30:66–73
Remuzzi G, Ruggenenti P, Perico N (2002) Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 136:604–615
Ruggenenti P, Schieppati A, Remuzzi G (2001) Progression, remission, regression of chronic renal diseases. Lancet 357:1601–1608
Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G (2008) Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 19:1213–1224
Obrador GT, Garcia-Garcia G, Villa AR, Rubilar X, Olvera N, Ferreira E, Virgen M, Gutierrez-Padilla JA, Plascencia-Alonso M, Mendoza-Garcia M, Plascencia-Perez S (2010) Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int Suppl 116:S2–S8
Luyckx VA, Brenner BM (2015) Birth weight, malnutrition and kidney-associated outcomes—a global concern. Nat Rev Nephrol 11:135–149
Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U (2014) The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2:e174–e181
ISN KHDC Guidelines (2005) http://www.theisn.org/programs/clinical-research-program. Accessed 11 Nov 2015
Cravedi P, Sharma SK, Bravo RF, Islam N, Tchokhonelidze I, Ghimire M, Pahari B, Thapa S, Basnet A, Tataradze A, Tinatin D, Beglarishvili L, Fwu CW, Kopp JB, Eggers P, Ene-Iordache B, Carminati S, Perna A, Chianca A, Couser WG, Remuzzi G, Perico N (2012) Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA. BMJ Open 2(5):e001357. doi:10.1136/bmjopen-2012-001357
Bottomley MJ, Kalachik A, Mevada C, Brook MO, James T, Harden PN (2011) Single estimated glomerular filtration rate and albuminuria measurement substantially overestimates prevalence of chronic kidney disease. Nephron Clin Pract 117:c348–c352
Chen N, Hsu CC, Yamagata K, Langham R (2010) Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia. Nephrol (Carlton) 15(Suppl 2):31–36
Sharma SK, Ghimire A, Carminati S, Remuzzi G, Perico N (2014) Management of chronic kidney disease and its risk factors in eastern Nepal. Lancet Glob Health 2:e506–e507
The International Society of Nephrology. A briefing on the global impact of kidney disease [online] (2011) http://www.cdn.theisn.org/images/stories/WHO_CKD_Brochure_LR.pdf. Accessed 18 Nov 2015
Remuzzi G, Horton R (2013) Acute renal failure: an unacceptable death sentence globally. Lancet 382:2041–2042
Mehta RL, Cerda J, Burdmann EA, Tonelli M, Garcia-Garcia G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385:2616–2643
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
None.
Rights and permissions
About this article
Cite this article
Perico, N., Remuzzi, G. Prevention programs for chronic kidney disease in low-income countries. Intern Emerg Med 11, 385–389 (2016). https://doi.org/10.1007/s11739-016-1425-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-016-1425-7